Innoviva, Inc. - Director, 10%+ Owner at Armata Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
ARMP on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Innoviva, Inc. since 9/20/2023

Holdings reported by Innoviva, Inc. for Armata Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16.4M $81.8M $5.00 Mar 31, 2022 Indirect
Common Stock 8.71M $43.6M $5.00 Mar 31, 2022 Direct
Warrants to Purchase Common Stock 8.71M $43.6M $5.00 Mar 31, 2022 Direct Common Stock
Warrants to Purchase Common Stock 2.69M $13.5M $5.00 Mar 31, 2022 Indirect Common Stock
Convertible Debt convertible into Common Stock $30M Jan 10, 2023 Indirect Common Stock

Transactions reported by Innoviva, Inc. for Armata Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.